<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Mepivacaine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00961</strong>&#160; (APRD01094)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>A local anesthetic that is chemically related to bupivacaine but pharmacologically related to lidocaine. It is indicated for infiltration, nerve block, and epidural anesthesia. Mepivacaine is effective topically only in large doses and therefore should not be used by this route. (From <span class="caps">AMA</span> Drug Evaluations, 1994, p168)</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00961/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00961/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00961.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00961.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00961.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00961.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00961.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00961">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>1-methyl-2',6'-pipecoloxylidide</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>DL-Mepivacaine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Mepivacaina</td><td>Spanish</td><td>INN</td></tr><tr><td>Mepivacainum</td><td>Latin</td><td>INN</td></tr><tr><td>N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Mepivacaine Hydrochloride</strong>
          <div class="cas">1722-62-9</div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000478/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000478/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: RETIMRUQNCDCQB-UHFFFAOYNA-N</li>
              <li>Monoisotopic Mass: 282.149891075</li>
              <li>Average Mass: 282.809</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000478">DBSALT000478</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Carbocaine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Isocaine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Polocaine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Scandicaine</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Scandonest Plain</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>2% Polocaine Dental with Levonordefrin 1:20,000</td><td>Corbadrine + Mepivacaine Hydrochloride</td></tr><tr><td>Arestocaine Hcl 2% W Levonordefrin 1:20000</td><td>Levonordefrin Hydrochloride + Mepivacaine Hydrochloride</td></tr><tr><td>Carbocaine 2% Neo-Cobefrin 1:20,000 Liq</td><td>Levonordefrin Hydrochloride + Mepivacaine Hydrochloride</td></tr><tr><td>Carbocaine 2% with Neo-Cobefrin</td><td>Corbadrine + Mepivacaine Hydrochloride</td></tr><tr><td>Isocaine Hcl Inj 2%</td><td>Levonordefrin Hydrochloride (Levonordefrin Hydrochloride) + Mepivacaine Hydrochloride</td></tr><tr><td>Mepivacaine Hcl 2% W Levonordefrin Inj</td><td>Levonordefrin Hydrochloride + Mepivacaine Hydrochloride</td></tr><tr><td>Scandonest 2% Special Inj</td><td>Epinephrine + Mepivacaine Hydrochloride</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anesthetics-local">Anesthetics, Local</a></li></ul></td></tr><tr><th>CAS number</th><td>96-88-8</td></tr><tr><th>Weight</th><td>Average: 246.348<br>Monoisotopic: 246.173213336</td></tr><tr><th>Chemical Formula</th><td>C<sub>15</sub>H<sub>22</sub>N<sub>2</sub>O</td></tr><tr><th>InChI Key</th><td>INWLQCZOYSRPNW-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C15H22N2O/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18)</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C</div></td></tr><tr><th>Mass Spec</th><td><a href="/system/mass_specs/DB00961.gif?1265922770">show</a>(7.1 KB)</td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organic Acids and Derivatives</td></tr><tr><th>Class</th><td>Carboxylic Acids and Derivatives</td></tr><tr><th>Subclass</th><td>Amino Acids, Peptides, and Analogues</td></tr><tr><th>Direct parent</th><td>Alpha Amino Acid Amides</td></tr><tr><th>Alternative parents</th><td>Anilides; Piperidinecarboxylic Acids; Toluenes; Secondary Carboxylic Acid Amides; Tertiary Amines; Enolates; Carboxylic Acids; Polyamines</td></tr><tr><th>Substituents</th><td>acetanilide; piperidinecarboxylic acid; toluene; piperidine; benzene; carboxamide group; secondary carboxylic acid amide; tertiary amine; polyamine; carboxylic acid; enolate; amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the alpha amino acid amides. These are amide derivatives of alpha amino acids.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For production of local or regional analgesia and anesthesia by local infiltration, peripheral nerve block techniques, and central neural techniques including epidural and caudal blocks.</td></tr><tr><th>Pharmacodynamics</th><td>Mepivicaine is a local anesthetic of the amide type. Mepivicaine as a reasonably rapid onset and medium duration and is known by the proprietary names as Carbocaine and Polocaine. Mepivicaine is used in local infiltration and regional anesthesia. Systemic absorption of local anesthetics produces effects on the cardiovascular and central nervous systems. At blood concentrations achieved with normal therapeutic doses, changes in cardiac conduction, excitability, refractoriness, contractility, and peripheral vascular resistance are minimal.</td></tr><tr><th>Mechanism of action</th><td>Local anesthetics block the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. In general, the progression of anesthesia is related to the diameter, myelination, and conduction velocity of affected nerve fibers. Clinically, the order of loss of nerve function is as follows: pain, temperature, touch, proprioception, and skeletal muscle tone.</td></tr><tr><th>Absorption</th><td>Absorbed locally. The rate of systemic absorption of local anesthetics is dependent upon the total dose and concentration of drug administered, the route of administration, the vascularity of the administration site, and the presence or absence of epinephrine in the anesthetic solution.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td>Mepivacaine is approximately 75% bound to plasma proteins. Generally, the lower the plasma concentration of drug, the higher the percentage of drug bound to plasma.</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Rapidly metabolized, with only a small percentage of the anesthetic (5 percent to 10 percent) being excreted unchanged in the urine. The liver is the principal site of metabolism, with over 50% of the administered dose being excreted into the bile as metabolites.</p></td></tr><tr><th>Route of elimination</th><td>It is rapidly metabolized, with only a small percentage of the anesthetic (5 percent to 10 percent) being excreted unchanged in the urine.The liver is the principal site of metabolism, with over 50% of the administered dose being excreted into the bile as metabolites.</td></tr><tr><th>Half life</th><td>The half-life of mepivacaine in adults is 1.9 to 3.2 hours and in neonates 8.7 to 9 hours.</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>The mean seizure dosage of mepivacaine in rhesus monkeys was found to be 18.8 mg/kg with mean arterial plasma concentration of 24.4 &#181;g/mL. The intravenous and subcutaneous LD 50 in mice is 23 mg/kg to 35 mg/kg and 280 mg/kg respectively.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th></tr></thead><tbody><tr><td>Mepivacaine Action Pathway</td><td>Drug action</td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9568</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9749</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.6836</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.7866</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Inhibitor
        </td>
        <td>0.6872</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8665</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.5878</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7853</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Substrate</td>
        <td>0.7423</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.7726</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.7996</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.933</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Inhibitor</td>
        <td>0.6146</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9387</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.5395</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.7497</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.8252
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9333
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.939
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          1.7237 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.908
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Inhibitor 
        </td>
        <td>
            0.6936
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Solvay pharmaceuticals</li>
<li>Eastman kodak co</li>
<li>Hospira inc</li>
<li>Novocol pharmaceutical inc</li>
<li>Graham chemical co</li>
<li>International medication system</li>
<li>Watson laboratories inc</li>
<li>App pharmaceuticals llc</li>
<li>Dentsply pharmaceutical</li>
<li>Deproco inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.gotoadc.com">American Dental Cooperative Inc.</a></li>
<li><a href="http://www.apppharma.com">APP Pharmaceuticals</a></li>
<li>Ato Zizine Sarl</li>
<li><a href="http://www.benco.com">Benco Dental Co.</a></li>
<li><a href="http://www.cardent.com">Cardent International Inc.</a></li>
<li><a href="http://www.carestreamhealth.com">Carestream Health Inc.</a></li>
<li>Carlisle Laboratories Inc.</li>
<li><a href="http://www.darbydental.com">Darby Dental Supply Co. Inc.</a></li>
<li><a href="http://www.dentsply.com">DENTSPLY International</a></li>
<li>Eastman Kodak Co. Dental Products</li>
<li>H Meer Dental Supply Co.</li>
<li><a href="http://www.henryschein.com">Henry Schein Inc.</a></li>
<li><a href="http://www.hospira.com">Hospira Inc.</a></li>
<li><a href="http://www.kentdentalclinic.yp.ca">Kent Dental</a></li>
<li>Les Laboratoires Medis S A</li>
<li><a href="http://www.novocol.com">Novocol Pharmaceutical Canada</a></li>
<li><a href="http://www.pattersondental.com">Patterson Dental Supply Inc.</a></li>
<li><a href="http://www.safcodental.com">Safco Dental Supply Co.</a></li>
<li><a href="http://www.septodont.com">Septodont Inc.</a></li>
<li><a href="http://www.spectrumpharm.com">Spectrum Pharmaceuticals</a></li>
<li>Veratex Corp.</li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Liquid</td><td>Infiltration</td><td></td></tr><tr><td>Solution</td><td>Infiltration</td><td></td></tr><tr><td>Solution</td><td>Subcutaneous</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>